193 related articles for article (PubMed ID: 32201513)
1. FRAT1 Enhances the Proliferation and Tumorigenesis of CD133
Guo G; Liu J; Ren Y; Mao X; Hao Y; Zhong C; Chen X; Wang X; Wu Y; Lian S; Mei L; Zhao Y
J Cancer; 2020; 11(9):2421-2430. PubMed ID: 32201513
[TBL] [Abstract][Full Text] [Related]
2. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of FRAT1 expression by RNA interference inhibits human glioblastoma cell growth, migration and invasion.
Guo G; Kuai D; Cai S; Xue N; Liu Y; Hao J; Fan Y; Jin J; Mao X; Liu B; Zhong C; Zhang X; Yue Y; Liu X; Ma N; Guo Y
PLoS One; 2013; 8(4):e61206. PubMed ID: 23613813
[TBL] [Abstract][Full Text] [Related]
4. Silencing of FRAT1 by siRNA inhibits the proliferation of SGC7901 human gastric adenocarcinoma cells.
Yu Q; Shang LU; Yu H; Yang Z; Xu D
Biomed Rep; 2016 Feb; 4(2):223-226. PubMed ID: 26893843
[TBL] [Abstract][Full Text] [Related]
5. [Overexpressed miRNA-134b inhibits proliferation and invasion of CD133
Liu Y; Zhang B; Wen C; Wen G; Zhou G; Zhang J; He H; Wang N; Li W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):637-642. PubMed ID: 28502302
[TBL] [Abstract][Full Text] [Related]
6. miR-139/PDE2A-Notch1 feedback circuit represses stemness of gliomas by inhibiting Wnt/β-catenin signaling.
Li SZ; Ren KX; Zhao J; Wu S; Li J; Zang J; Fei Z; Zhao JL
Int J Biol Sci; 2021; 17(13):3508-3521. PubMed ID: 34512162
[No Abstract] [Full Text] [Related]
7. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
8. The expression profile of FRAT1 in human gliomas.
Guo G; Mao X; Wang P; Liu B; Zhang X; Jiang X; Zhong C; Huo J; Jin J; Zhuo Y
Brain Res; 2010 Mar; 1320():152-8. PubMed ID: 20096670
[TBL] [Abstract][Full Text] [Related]
9. SOX15 exerts antitumor function in glioma by inhibiting cell proliferation and invasion via downregulation of Wnt/β-catenin signaling.
Zhang D; Guo S; Wang H; Hu Y
Life Sci; 2020 Aug; 255():117792. PubMed ID: 32416168
[TBL] [Abstract][Full Text] [Related]
10. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
[TBL] [Abstract][Full Text] [Related]
11. STAT1 is a modulator of the expression of frequently rearranged in advanced T-cell lymphomas 1 expression in U251 cells.
Guo G; Wang S; Hao Y; Ren Y; Wu Y; Zhang J; Liu D
Oncol Lett; 2020 Jul; 20(1):248-256. PubMed ID: 32565951
[TBL] [Abstract][Full Text] [Related]
12. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
[TBL] [Abstract][Full Text] [Related]
13. Silencing of ATM expression by siRNA technique contributes to glioma stem cell radiosensitivity in vitro and in vivo.
Li Y; Li L; Wu Z; Wang L; Wu Y; Li D; Ma U; Shao J; Yu H; Wang D
Oncol Rep; 2017 Jul; 38(1):325-335. PubMed ID: 28560406
[TBL] [Abstract][Full Text] [Related]
14. Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours.
Wang Y; Hewitt SM; Liu S; Zhou X; Zhu H; Zhou C; Zhang G; Quan L; Bai J; Xu N
Br J Cancer; 2006 Mar; 94(5):686-91. PubMed ID: 16479254
[TBL] [Abstract][Full Text] [Related]
15. LASS2 impairs proliferation of glioma stem cells and migration and invasion of glioma cells mainly via inhibition of EMT and apoptosis promotion.
Zhao WJ; Fan YP; Ou GY; Qiao XY
J Cancer; 2022; 13(7):2281-2292. PubMed ID: 35517425
[TBL] [Abstract][Full Text] [Related]
16. Dihydroartemisinin exhibits anti-glioma stem cell activity through inhibiting p-AKT and activating caspase-3.
Cao L; Duanmu W; Yin Y; Zhou Z; Ge H; Chen T; Tan L; Yu A; Hu R; Fei L; Feng H
Pharmazie; 2014 Oct; 69(10):752-8. PubMed ID: 25985565
[TBL] [Abstract][Full Text] [Related]
17. Frequently rearranged in advanced T‑cell lymphomas‑1 demonstrates oncogenic properties in prostate cancer.
Zhang W; Xiong H; Zou Y; Xu S; Quan L; Yuan X; Xu N; Wang Y
Mol Med Rep; 2016 Oct; 14(4):3551-8. PubMed ID: 27599661
[TBL] [Abstract][Full Text] [Related]
18. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL
Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
20. IDH1 mutation diminishes aggressive phenotype in glioma stem cells.
Yao Q; Cai G; Yu Q; Shen J; Gu Z; Chen J; Shi W; Shi J
Int J Oncol; 2018 Jan; 52(1):270-278. PubMed ID: 29115585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
